COMPLEMENT THERAPEUTICS
Complement Therapeutics operates as a preclinical stage company. Complement Therapeutics develops a precision medicine diagnostic platform allowing it to stratify patients based on their complement-activation profile with the potential to enable both patient selection and serving as an efficacy biomarker in future clinical studies.
COMPLEMENT THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical
Founded:
2020-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.complementtx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.65 M USD
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Advisors List
Current Employees Featured
Investors List
BioGeneration Ventures
BioGeneration Ventures investment in Seed Round - Complement Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Seed Round - Complement Therapeutics
BioGeneration Ventures
BioGeneration Ventures investment in Seed Round - Complement Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Seed Round - Complement Therapeutics
Official Site Inspections
http://www.complementtx.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Complement Therapeutics"
Complement Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Complement Therapeutics operates as a preclinical stage company. Complement Therapeutics develops a precision medicine diagnostic platform …See details»
Complement Therapeutics – Turning powerful new Complement …
Complement Therapeutics – Turning powerful new Complement System ...See details»
Complement Therapeutics - LinkedIn
Complement Therapeutics GmbH (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases.See details»
Board of Directors – Complement Therapeutics
Steve is currently the CEO of Glycomine, a clinical-stage company focused on developing new therapies for serious unserved orphan diseases. Steve has more than 20 years of corporate …See details»
Overview, News & Similar companies - ZoomInfo.com
Apr 17, 2023 View Complement Therapeutics (www.complementtx.com) location in Greater London, United Kingdom , revenue, industry and description. ... Complement Therapeutics has …See details»
Complement Therapeutics Company Profile | Management and
[email protected]: Complement Therapeutics Top Competitors. Company Employees Revenue Top technologies; Rexgenero Ltd. 20: $3.6 M: ReNeuron Group PLC. 26: $318 K: …See details»
Complement Therapeutics - Craft
Complement Therapeutics has 5 employees at their 1 location and $79.15 m in total funding,. See insights on Complement Therapeutics including office locations, competitors, revenue, …See details»
Complement Therapeutics | LinkedIn
Complement Therapeutics | 3,535 followers on LinkedIn. Developing the next generation of complement medicines | Complement Therapeutics GmbH (CTx) is an early-stage …See details»
Complement Therapeutics - Company Profile - Tracxn
Oct 19, 2024 Complement Therapeutics - Developer of gene therapies to treat retinal diseases. Raised a total funding of $84.8M over 3 rounds from 7 investors. Valued at $108M. Founded …See details»
Complement Therapeutics Information - RocketReach
Complementtx.com; 1 44238076XXXX; Jen Watts Vice President of Clinical Operations at Complement Therapeutics Dallas, Texas, United States View. 3 gmail.com; crc …See details»
Our Team – Complement Therapeutics
Matthias joins from Alexion Pharmaceuticals Inc., where he held the position of VP of Pipeline and Technology Development. Prior to that, he was Global Vice President of Technology …See details»
Complement Theraputics Secures Funding - Innovation Factory
Apr 17, 2023 Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement mediated diseases, today announced …See details»
Complement Therapeutics Appoints Dr Muhammad Ali Memon …
Nov 26, 2024 Complement Therapeutics Appoints Dr Muhammad Ali Memon FRCOphth, as Chief Medical Officer. Written by admin on November 26, 2024. Posted in Press Release. …See details»
Complement Therapeutics Enrols First Patient in Non ... - Forbion
London England – 09 February 2023 – Complement Therapeutics Ltd (CTx), a preclinical stage biotechnology company, today announced enrolment of the first patient in a natural history …See details»
CPM Platform – Complement Therapeutics
The CPM platform provides, for the first time, the opportunity to accurately measure an array complement proteins from a single systemically drawn blood sample.See details»
MHRA awards Complement Therapeutics Innovation Passport for …
London England – 1st November 2022 – Complement Therapeutics Ltd (CTx), a biotechnology company developing novel therapeutics for complement-related diseases, today announced its …See details»
News – Complement Therapeutics
Munich, Germany – 26th November 2024 - Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for...See details»
The Governor’s Committee To Support The Military Releases 2024 …
1 day ago December 16, 2024 | Austin, Texas | Press Release The Governor’s Committee to Support the Military today released their 2024 report with recommendations for policy changes …See details»
Complement Therapeutics Ltd raises EUR 5 Million Seed Financing …
Feb 23, 2022 References. Cipriani, V. et al. Beyond factor H: The impact of genetic-risk variants for age-related macular degeneration on circulating factor-H-like 1 and factor-H-related protein …See details»
Complement System – Complement Therapeutics
The complement system, also known as complement cascade, is a part of the immune system that enhances (complements) the ability of antibodies and phagocytic cells to clear microbes …See details»